Final ID: P2067
Wang Wendy, Crainiceanu Ciprian, Spira Adam, Schrack Jennifer, Chen Lin, Wanigatunga Amal, Etzkorn Lacey, Rabinowitz Jill, Palta Priya, Pike James, Dougherty Ryan, Zipunnikov Vadim, Marino Francesca
A First-In-Human Phase 1 Study of the Safety, Tolerability, and Pharmacodynamics of REGN7544, a Novel Natriuretic Peptide Receptor 1–Blocking Monoclonal AntibodyAhmed Mohsin, Morton Lori, Olenchock Benjamin, Herman Gary, Wynne Chris, Marin Ethan, Tuckwell Katie, Xu Meng, Cheng Xiping, Redington Emily, Koyani Bharatkumar, Mateo Katrina, Thakur Mazhar, Devalaraja-narashimha Kishor